ROLE OF MULTIPLEX REAL-TIME PCR IN MORNITORING TREATMENT OF VENTILATION ASSOCIATED PNEUMONIA

Thị Thu Hương Đinh 1, Ngọc Sơn Đỗ 2,, Vũ Huy Bùi3
1 Thanh Nhan hospital
2 Bahc Mai hospital
3 Hanoi medical university

Main Article Content

Abstract

Objective: To analyze the role of multiplex real-time PCR in monitoring treatment of ventilator associated pneumonia (VAP). Patients and methods: 242 patients ≥ 18 years with suspected VAP were randomly divided into 2 groups: control group in whom sputum routine culture, routine bronchial fluid was carried out as usual and study group in whom multiplex real-time PCR was performed to guide the antibiotic treament. Results: The rate of appropriate antibiotic used in the study group was 89/121 (73.6%) patients, control group 59/121 (48.8%) patients with p< 0.05. The duration of mechanical ventilation; the length in  ICU stay and the the length of hospital stay in study group shorter than that in control group with statistically significant (p<0.05). The overall mortality rate in the study group was 42/121 (34.7%) patients, the control group was 59/121 (48.8%) patients with p=0.022. There was no statistically significant difference in mortality due to VAP in the study group 26/121 (21.5%) patients and in the control group 36/121 (39.8%) patients with p=0.141. It is necessary to apply multiplex realtime PCR to at least 6 patients to reduce one patient's death due to VAP. Conclusions: Using multiplex real-time PCR results to treat VAP increase the use of appropriate antibiotics; reduce length in  ICU stay and the the length of hospital stay.

Article Details

References

1. Baudel J-L, Tankovic J, Dahoumane R, et al. Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study. Annals of intensive care. 2014;4(1):35.
2. CDC. Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event 2018;
3. CDC. Pneumonia (Ventilator-associated [VAP] and non-ventilator-associated Pneumonia [PNEU]) Event.
4. Vũ Đình Phú, Nadjm B, Duy NHA, et al. Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology. Journal of intensive care. 2017;5(1):69.
5. Borgatta B, Gattarello S, Mazo C, et al. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs. European Journal of Clinical Microbiology & Infectious Diseases. 2017;36(11):2155-2163.
6. Hội Hồi sức cấp cứu và chống độc Việt nam. Khuyến cáo chẩn đoán và điều trị viêm phổi bệnh viện, viêm phổi liên quan thở máy. 2017.
7. Zaragoza R, Vidal-Cortés P, Aguilar G, et al. Update of the treatment of nosocomial pneumonia in the ICU. Critical Care. 2020;24(1):1-13.
8. Monard C, Pehlivan J, Auger G, et al. Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Critical Care. 2020;24(1):1-11.
9. Vardakas K, Anifantaki F, Trigkidis K, Falagas M. Rapid molecular diagnostic tests in patients with bacteremia: evaluation of their impact on decision making and clinical outcomes. European Journal of Clinical Microbiology & Infectious Diseases. 2015;34(11):2149-2160.
10. Nguyễn Văn Tuấn. Đo lường hiệu quả điều trị: Nguy cơ tuyệt đối và số bệnh nhân cần điều trị.